Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A US health panel advises starting mammograms at age 40 rather than 50.

2.

Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer

3.

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

4.

Spicy Chip Death Lawsuit; Gen X and Cancer; Extreme U.S. Temperatures

5.

Distribution of fat could influence cancer risk, study suggests


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot